SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891618-02-005491
Filing Date
2002-12-12
Accepted
2002-12-12 08:01:33
Documents
1
Period of Report
2003-01-14
Effectiveness Date
2002-12-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE SPECIAL PROXY STATEMENT f86163dedef14a.htm DEF 14A 108514
  Complete submission text file 0000891618-02-005491.txt   110054
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22570 | Film No.: 02855183
SIC: 2833 Medicinal Chemicals & Botanical Products